Abnormal Uterine Bleeding: An Identification and Quantification of the Evaluation Criteria Used by Ob/Gyn Surgeons to Evaluate Global Endometrial Ablation Companies

Valid Results, April 2008

An in-depth measurement of the various criteria Ob/Gyn surgeons use to evaluate manufactures, as well as the level of influence each criterion has in the evaluation process. The analyses also examine the differences in the evaluation processes of various obstetrics and gynecology segments, including those who specialize in AUB patients, AUB procedures and/or GEA procedures. Provides an understanding of how company images and positioning evolve.

Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.

The number of respondents to this survey is 40. We also have more studies available with increased survey respondents. Please use our Contact Us page for further details on pricing.

Due to the custom analysis of this report, a table of contents will not be available until the report is purchased

Customers who bought this item also bought

• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
• IV Fluid Transfer Devices Products, Players, Markets and Opportunities
• RNA Interference (RNAi) - Global Strategic Business Report
• Truck Bedliners - Global Strategic Business Report
• Nuclear Medicine - Global Strategic Business Report
• Pain Management Devices - Global Strategic Business Report
• Pediatric Drugs and Vaccines - Global Business Strategic Report
• North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics– Forecasts to 2017
• Oncology Partnering Terms and Agreements